Sun Pharmaceuticals Industries' Stock Soars, Outperforms Sector and Market
Sun Pharmaceuticals Industries, a leading player in the pharmaceuticals and drugs industry, has been making headlines with its recent stock performance. On September 27, 2024, the company's stock gained 3.09%, outperforming the sector by 2.32%. This positive trend has been consistent for the last two days, with a total return of 4.73%. The stock also hit a new 52-week and all-time high, showcasing its strong performance and growth potential. With a 'Buy' call from MarketsMojo and outperforming the market, Sun Pharmaceuticals Industries is a stable and reliable investment option with strong fundamentals and growth potential.
Sun Pharmaceuticals Industries, a leading player in the pharmaceuticals and drugs industry, has been making headlines with its recent stock performance. On September 27, 2024, the company's stock gained 3.09%, outperforming the sector by 2.32%. This positive trend has been consistent for the last two days, with a total return of 4.73% during this period.
The stock of Sun Pharmaceuticals Industries also hit a new 52-week and all-time high of Rs.1959.35 on the same day. This is a significant milestone for the company, showcasing its strong performance and growth potential. In fact, the stock has been trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bullish trend.
MarketsMOJO, a leading stock analysis and recommendation platform, has given a 'Buy' call for Sun Pharmaceuticals Industries. This further reinforces the positive sentiment surrounding the company's stock.
In comparison to the overall market performance, Sun Pharmaceuticals Industries has outperformed the Sensex by 2.86% in the last 1 day and 9.07% in the last 1 month. This is a testament to the company's strong fundamentals and growth potential.
Sun Pharmaceuticals Industries is a largecap company, making it a stable and reliable investment option for investors. With its consistent positive performance and strong market position, the company is poised for further growth in the pharmaceuticals and drugs industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
